120 related articles for article (PubMed ID: 8824364)
1. Serum androgens and prostate cancer.
Nomura AM; Stemmermann GN; Chyou PH; Henderson BE; Stanczyk FZ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):621-5. PubMed ID: 8824364
[TBL] [Abstract][Full Text] [Related]
2. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649
[TBL] [Abstract][Full Text] [Related]
3. Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.
Gill JK; Wilkens LR; Pollak MN; Stanczyk FZ; Kolonel LN
Prostate; 2010 Jun; 70(8):906-15. PubMed ID: 20166103
[TBL] [Abstract][Full Text] [Related]
4. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
[TBL] [Abstract][Full Text] [Related]
5. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
; Roddam AW; Allen NE; Appleby P; Key TJ
J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
[TBL] [Abstract][Full Text] [Related]
6. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
8. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii.
Nomura AM; Stemmermann GN; Lee J; Craft NE
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):487-91. PubMed ID: 9232334
[TBL] [Abstract][Full Text] [Related]
9. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
11. Androgens and prostate cancer risk: a prospective study.
Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
[TBL] [Abstract][Full Text] [Related]
12. Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer.
Vijayakumar S; Quadri SF; Dong L; Ignacio L; Kathuria IN; Sutton H; Halpern H
J Natl Med Assoc; 1995 Nov; 87(11):813-9. PubMed ID: 8907816
[TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
14. 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.
Guess HA; Friedman GD; Sadler MC; Stanczyk FZ; Vogelman JH; Imperato-McGinley J; Lobo RA; Orentreich N
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):21-4. PubMed ID: 8993793
[TBL] [Abstract][Full Text] [Related]
15. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
16. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
Rittmaster RS; Stoner E; Thompson DL; Nance D; Lasseter KC
J Androl; 1989; 10(4):259-62. PubMed ID: 2550402
[TBL] [Abstract][Full Text] [Related]
17. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
18. Serum selenium and subsequent risk of prostate cancer.
Nomura AM; Lee J; Stemmermann GN; Combs GF
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):883-7. PubMed ID: 11008904
[TBL] [Abstract][Full Text] [Related]
19. Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.
Rouleau M; Neveu B; Caron P; Morin F; Toren P; Lacombe L; Turcotte V; Lévesque É; Guillemette C; Pouliot F
J Urol; 2022 Dec; 208(6):1214-1225. PubMed ID: 36102111
[TBL] [Abstract][Full Text] [Related]
20. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
